Tumor visibility | Technical feasibility | |||||
---|---|---|---|---|---|---|
US-FI | CEUS-CT/MR FI | P value | US-FI | CEUS-CT/MR FI | P value | |
Total | 1.9 ± 0.6 | 3.4 ± 0.7 | < 0.001 | 2.9 ± 0.8 | 3.6 ± 0.6 | < 0.001 |
By location | ||||||
Left lobe | 2.0 ± 0.7 | 3.5 ± 0.7 | < 0.001 | 2.8 ± 0.8 | 3.5 ± 0.6 | < 0.001 |
Right superior segments | 1.9 ± 0.6 | 3.3 ± 0.8 | < 0.001 | 2.8 ± 0.8 | 3.5 ± 0.7 | < 0.001 |
Right inferior segments | 1.9 ± 0.6 | 3.4 ± 0.7 | < 0.001 | 3.0 ± 0.8 | 3.8 ± 0.5 | < 0.001 |
By size | ||||||
< 2 cm | 1.8 ± 0.6 | 3.3 ± 0.8 | < 0.001 | 2.8 ± 0.9 | 3.6 ± 0.7 | < 0.001 |
≥ 2 cm, < 2.5 cm | 2.0 ± 0.5 | 3.6 ± 0.5 | < 0.001 | 3.0 ± 0.7 | 3.7 ± 0.5 | < 0.001 |
≥ 2.5 cm | 2.4 ± 0.5 | 3.6 ± 0.5 | < 0.001 | 3.3 ± 0.6 | 3.7 ± 0.5 | 0.014 |
By contrast agent | ||||||
SonoVue | 1.9 ± 0.7 | 3.4 ± 0.8 | < 0.001 | 2.9 ± 0.9 | 3.7 ± 0.6 | < 0.001 |
Sonazoid | 1.8 ± 0.5 | 3.4 ± 0.7 | < 0.001 | 2.8 ± 0.8 | 3.6 ± 0.6 | < 0.001 |